Although activation of NF-κB is required to protect organisms from adverse environmental effects, the deregulated activity of NF-κB leads to the development of cancer and various autoimmune disorders, including rheumatoid arthritis, atherosclerosis, inflammatory bowel diseases, and multiple sclerosis. Here, NFKB1 is linked to inflammatory bowel disease.